Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Bischoff, H. Garassino, M. C. Mazieres, J. Reck, M. Chouaid, C. Cove-Smith, Laura Mansy, T. Migliorino, M. R. Delmonte, A. Sanchez, J. G.
Bischoff, H.
Garassino, M. C.
Mazieres, J.
Reck, M.
Chouaid, C.
Cove-Smith, Laura
Mansy, T.
Migliorino, M. R.
Delmonte, A.
Sanchez, J. G.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Bischoff H, Garassino MC, Mazieres J, Reck M, Chouaid C, Cove-Smith L, et al. Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6). Oncology Research and Treatment. 2022 Nov;45(SUPPL 3):160-1. PubMed PMID: WOS:000883051700375.